Evidence map›Paper›PMID 31484695›Full record

ArticleJournal of lipid research2019

Effects of diet and hyperlipidemia on levels and distribution of circulating lysophosphatidic acid.

Maria P Kraemer, Guogen Mao, Courtney Hammill, Baoxiang Yan, Yu Li, Fredrick Onono, Susan S Smyth, Andrew J Morris

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Bioactive lipids and metabolic syndrome-a symposium report.Annals of the New York Academy of Sciences · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Lysolipids in Vascular Development, Biology, and Disease.Arteriosclerosis, thrombosis, and vascular biology · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Maria P KraemerDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY.
Guogen MaoDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY.
Courtney HammillDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY.
Baoxiang YanDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY.
Yu LiDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY.
Fredrick OnonoDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY.ORCID 0000-0003-3827-5045
Susan S SmythDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY.
Andrew J MorrisDivision of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY a.j.morris@uky.edu.ORCID 0000-0003-1910-4865
University of Kentucky · US

Funding

The role of IKKß in linking obesity to adipose tissue inflammation and adipogeneP20GM103527 · NIGMS · UNIVERSITY OF KENTUCKY · PI CASSIS, LISA A · 2012 to 2017
$13.7M
Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressorR01HL120507 · NHLBI · UNIVERSITY OF KENTUCKY · PI MORRIS, ANDREW J, SMYTH, SUSAN S. · 2015 to 2018
$2.1M
Intestinal phosphatidylcholine exposure and breast cancer riskK01CA197073 · NCI · UNIVERSITY OF KENTUCKY · PI ONONO, FREDRICK ONYANGO · 2015 to 2019
$702k
Association of a common variant of the PPAP2B gene with cardiovascular disease.I01BX001984 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI MORRIS, ANDREW J · 2013 to 2016
–
Lysophosphatidic acid and cardiovascular disease riskI01CX001550 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI MORRIS, ANDREW J · 2017 to 2021
–
Acquisition of an HPLC Electrospray/chemical ionization triple quadrupole linear ion trap mass spectrometer system.IS1BX003153 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI MORRIS, ANDREW J · 2015 to 2015
–
BLRD VA I01 BX001984BLRD VA IS1 BX003153CSRD VA I01 CX001550NCI NIH HHS K01 CA197073NHLBI NIH HHS R01 HL120507NIGMS NIH HHS P20 GM103527
6 · The paper itself

Abstract

Lysophosphatidic acids (LPAs) are bioactive radyl hydrocarbon-substituted derivatives of glycerol 3-phosphate. LPA metabolism and signaling are implicated in heritable risk of coronary artery disease. Genetic and pharmacological inhibition of these processes attenuate experimental atherosclerosis. LPA accumulates in atheromas, which may be a consequence of association with LDLs. The source, regulation, and biological activity of LDL-associated LPA are unknown. We examined the effects of experimental hyperlipidemia on the levels and distribution of circulating LPA in mice. The majority of plasma LPA was associated with albumin in plasma from wild-type mice fed normal chow. LDL-associated LPA was increased in plasma from high-fat Western diet-fed mice that are genetically prone to hyperlipidemia (LDL receptor knockout or activated proprotein convertase subtilisin/kexin type 9-overexpressing C57Bl6). Adipose-specific deficiency of the

Indexed as

DietAdipose TissueAnimalsCohort StudiesDiet, WesternHumansHydrolysisHyperlipidemiasHypolipidemic AgentsLipoproteins, LDLLysophospholipase DLysophospholipidsMiceMice, Inbred C57BLPhosphoric Diester HydrolasesHypolipidemic AgentsLipoproteins, LDLlysophosphatidic acidLysophospholipase DLysophospholipidsPhosphoric Diester Hydrolasesautotaxincholesterollipoproteinlow density lipoproteinmass spectrometry

Identifiers

PMID31484695
PMCPMC6824489
OpenAlexW2971793575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.